ENBI — Entheon Biomedical Income Statement
0.000.00%
Last trade - 00:00- CA$1.66m
- CA$1.14m
- 31
- 15
- 30
- 14
Annual income statement for Entheon Biomedical, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.022 | 0.19 | 0.25 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.009 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.167 | 9.13 | 3.79 | 0.563 | 0.333 |
| Operating Profit | -0.167 | -9.11 | -3.6 | -0.313 | -0.333 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.147 | -8.89 | -2.06 | -0.3 | -0.318 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.147 | -8.89 | -2.06 | -0.3 | -0.318 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.147 | -8.89 | -8.52 | -0.3 | -0.318 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.147 | -8.89 | -8.52 | -0.3 | -0.318 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.243 | -1.64 | -0.575 | -0.051 | -0.041 |